TABLE OF CONTENTS

Volume 64, Issue S87 (November 2003)

Top

Management of Comorbidities in Kidney Disease in the 21st Century: Anemia And Bone Disease

Dedication FREE

Morrell Michael Avram M.D

Kidney Int 64: S1-S1; doi:10.1046/j.1523-1755.64.s87.1.x

Resumative synthesis of contents: It is time for further renoprotection FREE

Morrell Michael Avram

Kidney Int 64: S2-S5; doi:10.1046/j.1523-1755.64.s87.2.x

Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin FREE

Morrell Michael Avram, Daniel Blaustein, Paul A Fein, Naveen Goel, Jyotiprakas Chattopadhyay and Neal Mittman

Kidney Int 64: S6-S11; doi:10.1046/j.1523-1755.64.s87.3.x

Prospective trials on anemia of chronic disease: The Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT) FREE

Madhumathi Rao and Brian J G Pereira

Kidney Int 64: S12-S19; doi:10.1046/j.1523-1755.64.s87.21.x

Anemia of chronic disease: Past, present, and future FREE

Robert D Toto

Kidney Int 64: S20-S23; doi:10.1046/j.1523-1755.64.s87.4.x

Chronic kidney disease and cardiovascular disease in the Medicare population FREE

Allan J Collins, Shuling Li, David T Gilbertson, Jiannong Liu, Shu-Cheng Chen and Charles A Herzog

Kidney Int 64: S24-S31; doi:10.1046/j.1523-1755.64.s87.5.x

Anemia as a risk factor for cardiovascular disease FREE

Arema A Pereira and Mark J Sarnak

Kidney Int 64: S32-S39; doi:10.1046/j.1523-1755.64.s87.6.x

Erythropoietin should be part of congestive heart failure management FREE

Donald S Silverberg, Dov Wexler, Miriam Blum, Doran Schwartz, Yoram Wollman and Adrian Iaina

Kidney Int 64: S40-S47; doi:10.1046/j.1523-1755.64.s87.7.x

Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure FREE

Donna M Mancini and Chandra Kunavarapu

Kidney Int 64: S48-S52; doi:10.1046/j.1523-1755.64.s87.8.x

Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients FREE

Robert Mushnick, Paul A Fein, Neal Mittman, Naveen Goel, Jyotiprakas Chattopadhyay and Morrell M Avram

Kidney Int 64: S53-S56; doi:10.1046/j.1523-1755.64.s87.22.x

Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease FREE

Eli A Friedman, Francis A L'Esperance Jr, Clinton D Brown and David H Berman

Kidney Int 64: S57-S63; doi:10.1046/j.1523-1755.64.s87.9.x

Controversies in iron management FREE

Allen R Nissenson and Chaim Charytan

Kidney Int 64: S64-S71; doi:10.1046/j.1523-1755.64.s87.10.x

The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease FREE

Daniel A Blaustein, Michael H Schwenk, Jyoti Chattopadhyay, Harinder Singh, Rachid Daoui, Radjeep Gadh and Morrell M Avram

Kidney Int 64: S72-S77; doi:10.1046/j.1523-1755.64.s87.11.x

Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance FREE

Roger N Greenwood, Claudio Ronco, Fiorella Gastaldon, Alessandra Brendolan, Peter Homel, Len Usvyat, Lenore Bruno, Mary Carter and Nathan W Levin

Kidney Int 64: S78-S86; doi:10.1046/j.1523-1755.64.s87.12.x

Malnutrition and inflammation in peritoneal dialysis patients FREE

Paul A Fein, Neal Mittman, Rajdeep Gadh, Jyotiprakas Chattopadhyay, Daniel Blaustein, Robert Mushnick and Morrell M Avram

Kidney Int 64: S87-S91; doi:10.1046/j.1523-1755.64.s87.13.x

Serum albumin concentration in dialysis patients: Why does it remain resistant to therapy? FREE

George A Kaysen

Kidney Int 64: S92-S98; doi:10.1046/j.1523-1755.64.s87.14.x

Transforming growth factor beta and progression of renal disease FREE

Phyllis August and Manikkam Suthanthiran

Kidney Int 64: S99-S104; doi:10.1046/j.1523-1755.64.s87.15.x

Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor FREE

Saulo Klahr and Jeremiah Morrissey

Kidney Int 64: S105-S112; doi:10.1046/j.1523-1755.64.s87.16.x

Overview of renal bone disease: Causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach FREE

Francisco Llach and Elvira Fernández

Kidney Int 64: S113-S119; doi:10.1046/j.1523-1755.64.s87.17.x

New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure FREE

William G Goodman

Kidney Int 64: S120-S124; doi:10.1046/j.1523-1755.64.s87.18.x

An update on vitamin D as related to nephrology practice: 2003 FREE

Jack W Coburn

Kidney Int 64: S125-S130; doi:10.1046/j.1523-1755.64.s87.19.x

The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease FREE

Geoffrey A Block

Kidney Int 64: S131-S136; doi:10.1046/j.1523-1755.64.s87.20.x

Extra navigation

.
ADVERTISEMENT